Barclays’s Mural Oncology MURA Stock Holding History

Barclays’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-55	Closed	-$114	–	5528
2025 Q3	$114	Buy	55 +51	+1,275%	+$110	﹤0.01%	5268
2025 Q2	$10	Hold	4	–	–	﹤0.01%	5156
2025 Q1	$5	Sell	4 -51	-93%	-$186	﹤0.01%	5193
2024 Q4	$177	Sell	55 -44	-44%	-$155	﹤0.01%	5176
2024 Q3	$310	Sell	99 -10	-9%	-$33	﹤0.01%	5160
2024 Q2	$342	Sell	109 -11,608	-99%	-$42.8K	﹤0.01%	4721
2024 Q1	$57.3K	Sell	11,717 -14,237	-55%	-$69.1K	﹤0.01%	4588
2023 Q4	$154K	Buy	+25,954	New	+$104K	﹤0.01%	4522

Barclays's MURA Position: Q4 2025 in Review

Barclays sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 55 shares — an estimated $114 sold.

Barclays first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $154K in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Barclays reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Barclays sold 55 Mural Oncology shares in Q4 2025, an estimated $114.
Barclays first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Barclays's Mural Oncology position peaked at $154K in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.